戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 take of microcin B17, microcin J25 (formerly microcin 25), and bleomycin.
2                                              Microcins are a class of ribosomally synthesized antibac
3                                   While some microcins are active as unmodified peptides, others are
4 lecular-weight post-translationally modified microcins are produced by Escherichia coli, inferences b
5                                              Microcins are small secreted proteins that possess antim
6                                              Microcin B17 (MccB17) is a 3.1-kDa Escherichia coli anti
7                                              Microcin B17 (MccB17) is a peptidyl antibiotic that is s
8                                              Microcin B17 (MccB17) is a ribosomally encoded DNA-gyras
9 aturation of the Escherichia coli antibiotic Microcin B17 (MccB17), the McbA prepro-antibiotic is mod
10 ta about three such microcins--microcin J25, microcin B17 and microcin C7-C51--are discussed.
11                                              Microcin B17 has no detectable effect on gyrase-catalyse
12                                              Microcin B17 is a 3.1-kDa bactericidal peptide; the puta
13                              Esherichia coli microcin B17 is a posttranslationally modified peptide t
14 eavage produced by gyrase in the presence of microcin B17 is different from that produced by quinolon
15  these motifs (D132, D147, and D199) reduced Microcin B17 production in vivo and heterocycle formatio
16 gue 5'-adenylyl beta,gamma-imidodiphosphate, microcin B17 stabilises a gyrase-dependent DNA cleavage
17 eterocycle formation, and an enzyme complex, microcin B17 synthase, was purified and found to contain
18 ding and downstream heterocycle formation by microcin B17 synthase.
19                                          The microcin B17 synthetase converts glycine, serine, and cy
20 zoles and four oxazoles by the three subunit Microcin B17 synthetase.
21                    To produce the antibiotic Microcin B17, four Cys and four Ser residues are convert
22 omycin, gramicidin S, rapamycin, indolmycin, microcin B17, fumagillin, mycotoxins, Monascus pigments,
23 f BacA, SbmA, is implicated in the uptake of microcin B17, microcin J25 (formerly microcin 25), and b
24 bmA mutants, namely, increased resistance to microcin B17, microcin J25, and bleomycin, demonstrating
25 aturation of the Escherichia coli antibiotic Microcin B17, the product of the mcbA gene is modified p
26 ght to protect DNA gyrase from the action of microcin B17.
27 aturation of the Escherichia coli antibiotic Microcin B17.
28 ro that confer antibiotic activity on mature microcin B17.
29 nzymes involved in thiazole/oxazole-modified microcin biosynthesis, a rapidly growing sector of natur
30 ng homology to genes of the Escherichia coli Microcin C (McC) biosynthetic pathway.
31                        Translation inhibitor microcin C (McC) is a heptapeptide with an aspartate alp
32                                              Microcin C (McC) is a peptide-nucleotide antibiotic prod
33                                              Microcin C (McC) is a peptide-nucleotide antibiotic that
34                                              Microcin C (McC) is a potent antibacterial agent produce
35                                              Microcin C (McC) is heptapeptide adenylate antibiotic pr
36                Peptide-nucleotide antibiotic microcin C (McC) is produced by some Escherichia coli st
37                                              Microcin C (McC), a peptide-nucleotide Trojan horse anti
38                                              Microcin C and related antibiotics are Trojan-horse pept
39                                  Recently, a microcin C homologue from Bacillus amyloliquefaciens con
40                                              Microcin C is a heptapeptide-adenylate antibiotic produc
41                    Here, we describe a novel microcin C-like compound from Bacillus amyloliquefaciens
42                                 We show that microcin C-like compounds carrying terminal cytosines ar
43 g sensitive cells in the same way as E. coli microcin C.
44                               The antibiotic microcin C7 (McC) acts as a bacteriocide by inhibiting a
45 tyl tRNA synthetase "Trojan horse" inhibitor microcin C7 (McC7) consists of a nonhydrolyzable asparty
46 oducer strains of Escherichia coli to afford microcin C7 (MccC7), a "Trojan horse" antibiotic that co
47 MccA heptapeptide during the biosynthesis of microcin C7 (MccC7), a 'Trojan horse' antibiotic.
48 ch microcins--microcin J25, microcin B17 and microcin C7-C51--are discussed.
49 ng those that are structurally distinct from microcin C7.
50                       Moreover, we show that microcins can act as narrow-spectrum therapeutics to inh
51                                              Microcin E492 (Mcc) is a pore-forming bacteriotoxin.
52                                              Microcin E492 (Mcc), a low molecular weight bacteriocin
53 chinery, to the C-terminal serine residue of microcin E492 (MccE492), an 84 aa ribosomal antibiotic p
54 e remarkable post-translational tailoring of microcin E492 (MccE492), an 84-residue protein toxin sec
55                             The finding that microcin E492 naturally exists both as functional toxic
56                          We report here that microcin E492, a peptide naturally produced by Klebsiell
57                     Here we demonstrate that microcins enable the probiotic bacterium Escherichia col
58                              We suggest that microcin exerts its effects through a mechanism that has
59                         Low-molecular-weight microcins from the post-translationally modified group t
60 sed on immunity to the antimicrobial peptide microcin H47 (MccH47).
61 strate fragments of the structurally related microcins H47, I47, and M.
62 ne-resistant mutants, are cross resistant to microcin-induced DNA cleavage.
63 is implicated in the uptake of microcin B17, microcin J25 (formerly microcin 25), and bleomycin.
64                                      Peptide microcin J25 (MccJ25) inhibits bacterial RNA polymerase.
65                    The antibacterial peptide microcin J25 (MccJ25) inhibits transcription by bacteria
66                        21 amino acid peptide Microcin J25 (MccJ25) inhibits transcription by bacteria
67                                              Microcin J25 (MccJ25) is a 21-amino acid peptide inhibit
68                                              Microcin J25 (MccJ25) is a 21-residue plasmid-encoded ri
69                                              Microcin J25 (MccJ25) is a ribosomally synthesized antim
70                                              Microcin J25 (MccJ25) is an antimicrobial peptide with a
71                    The antimicrobial peptide microcin J25 (MccJ25) is matured by two enzymes, McjB an
72             Mutagenesis of the lasso peptide microcin J25 (MccJ25) with two cysteine residues followe
73  to make Escherichia coli cells resistant to microcin J25 (MccJ25), a bactericidal 21-amino acid pept
74 tructure of capistruin is similar to that of microcin J25 (MccJ25), a threaded-lasso antibacterial pe
75 amely, increased resistance to microcin B17, microcin J25, and bleomycin, demonstrating the functiona
76  functional data about three such microcins--microcin J25, microcin B17 and microcin C7-C51--are disc
77  chemical syntheses of the cyclic antibiotic microcin J25, the 56-amino acid streptococcal protein G
78 press and secrete the antimicrobial peptide, Microcin J25.
79    Our work provides the first evidence that microcins mediate inter- and intraspecies competition am
80 uctural and functional data about three such microcins--microcin J25, microcin B17 and microcin C7-C5
81                                              Microcin PDI inhibits a diversity of pathogenic Escheric
82                                              Microcin-producing EcN limits the growth of competitors
83 therapeutic administration of the wild-type, microcin-producing EcN to mice previously infected with
84 regulation of iron acquisition, capsule, and microcin secretion genes, thus partially mimicking growt
85 lysaccharide synthesis, drug resistance, and microcin secretion.
86 dified posttranslationally by the multimeric Microcin synthetase complex (composed of McbB, C, and D)
87 ified post-translationally by the multimeric microcin synthetase complex (composed of the McbB, -C, a
88 the overexpression and rapid purification of microcin synthetase has been developed using a calmoduli
89 k indicate that MccPDI is unique amongst the microcins that have been described to date.
90 e repurposing of a thiazole/oxazole-modified microcin (TOMM) cyclodehydratase to site-specifically in
91                    Thiazole/oxazole-modified microcins (TOMMs) are a class of post-translationally mo
92                The thiazole/oxazole-modified microcins (TOMMs) represent a burgeoning class of riboso
93 novel siderophore receptors), cvaC (colicin [microcin] V), traT (serum-resistance associated), ibeA (
94 th antibiotic biosynthesis in vivo, yielding microcin with six, seven, and eight rings, all with bioa

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。